Office of Biotechnology Activities, Office of Science Policy, Office of the Director, Notice of Meeting, 32992 [06-5150]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• National Institutes of Health

[Federal Register Volume 71, Number 109 (Wednesday, June 7, 2006)]
[Notices]
[Page 32992]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director, Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Science Advisory Board for Biosecurity (NSABB).
    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established NSABB to provide advice, guidance and leadership regarding 
federal oversight of dual use research, defined as biological research 
with legitimate scientific purpose that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open the public, however pre-registration is 
strongly recommended due to space limitations. Persons planning to 
attend should register online at https://www.biosecurityboard.gov/
meetings.asp or by calling Capitol Consulting Corporation (Contact: 
Saundra M. Bromberg), at 301-468-6004, ext. 406. Individuals who plan 
to attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate 
these requirements upon registration.

    Name of Committee: National Advisory Board for Biosecurity.
    Date: July 13, 2006.
    Open: 8 a.m. to 6 p.m.
    Agenda: Presentations and discussions regarding: (1) Criteria 
for defining dual use research in the life sciences; (2) the role of 
a code of conduct for the life sciences; (3) communications of dual 
use research; (4) international perspectives on dual use research; 
(5) public comments; and (6) and other business of the Board.
    Place: The National Institutes of Health, 31 Center Drive, 
Building 31, 6C--Room 10, Bethesda, Maryland 20892.
    Contact Person: Laurie Lelwallen, NSABB Program Assistant, 6705 
Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.
    This meeting will also be Webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the Webcast and pre-registration, will be available at https://
www.biosecurityboard.gov/meetings.asp.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee. All written comments must be received by June 30, 2006 
and should be sent via e-mail to nsabb@od.nih.gov with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Laurie 
Lewallen. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: May 21, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5150 Filed 6-6-06; 8:45 am]
BILLING CODE 4140-01-M